Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging

Australasian Radiology

Volumn 48, Issue 3, 2004, Pages 324-332

  Batra, A ^a   Tripathi, R P ^a   Singh, A K ^b  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

Brain tumours; MR spectroscopy; Perfusion MRI

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TUMOR CLASSIFICATION;

ADULT; BLOOD VOLUME; BRAIN; CHOLINE; CREATINE; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; SUPRATENTORIAL NEOPLASMS;

EID: 7044226592     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0004-8461.2004.01315.x     Document Type: Article

References (28)

1. Aronen HJ, Gazit IE, Louis DN et al. Cerebral blood volume maps of gliomas. Comparison with tumour grade and histological findings. Radiology 1994; 191:41-51.
2. Sugahara T, Korogi Y, Kochi M et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR 1998; 171: 1479-86.
3. Dowling C, Bollen AW, Noworolski SM et al. Pre-operative proton MR spectroscopic imaging of brain tumours: correlation with histopathological analysis of resection specimens. AJNR 2001; 22: 604-12.
4. Ludemann L, Grieger W, Wurm R, Budzisch M, Hamm B, Zimmer C. Comparison of dynamic contrast enhanced MRI with WHO tumour grading of gliomas. Eur Radiol 2001; 11: 1231-41.
5. Lam WW, Chan KW, Wong WL, Poon WS, Metriweli C. Pre-operative grading of intracranial glioma. Acta Radiol 2001; 42: 548-54.
6. Tzika AA, Zarifi MK, Goumnerova L et al. Neuroimaging in pediatric brain tumours: Gd-DTPA enhanced hemodynamic and diffusion MR imaging compared with MR spectroscopic imaging. AJNR 2002; 23: 322-33.
7. Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumours using dynamic susceptibility contrast MR imaging. AJR 2002; 178: 711-16.
8. Essig M, Wenz F, Scholdei R et al. Dynamic susceptibility contrast enhanced echo-planar imaging of cerebral gliomas. Acta Radiol 2002; 43: 354-9.
9. Shin JH, Lee HK, Kwun BD et al. Using relative cerebral blood flow and volume to evaluate the histopathological grade of cerebral gliomas: preliminary results. AJR 2002; 179: 783-9.
10. Majos C, Alonso J, Aguilera C et al. Proton magnetic resonance spectroscopy of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol 2003; 13: 582-91.
11. Villringer A, Rosen BR, Belliveau JW et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988; 6: 164-74.
12. Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988; 38: 1371-4.
13. Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993; 79: 533-6.
14. Perez-Cruet MJ, Adelman L, Anderson M, Roth PA, Ritter AM, Saris SC. CT guided stereotactic biopsy of non-enhancing brain lesions. Sterotact Funct Neurosurg 1993; 61: 105-17.
15. Ginsberg LE, Fuller Gn, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumours in adults: histopathological evaluation of a series. Surg Neurol 1998; 49: 436-40.
16. Knopp E, Cha S, Johnson G et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211: 791-8.
17. Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain tumours. AJR 2000; 174: 1147-57.
18. Cho SK, Na DG, Ryoo JW et al. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumours. Korean J Radiol 2002; 3: 171-9.
19. Rees JH, Smirniotopoulos JG, Jones RV et al. Glioblastoma multiforme: radiologic-pathologic correlation. Radiographics 1996; 16: 1413-38.
20. Lee SJ, Kim JH, Kim YM, Wong K. Perfusion MR imaging in gliomas: comparison with histologic tumour grade. Korean J Radiol 2001; 2: 1-7.
21. Rosen BR, Aronen HJ, Kwong KK, Belliveau JW, Hamberg LM, Fordham JA. Advances in clinical neuroimaging: functional MR imaging techniques. Radiographics 1993; 13: 889-96.
22. Aronen HJ, Glass J, Pardo FS et al. Echoplanar MR cerebral blood volume mapping of gliomas. Acta Radiol 1995; 36: 520-8.
23. Yang D, Korogi Y, Sugahara T et al. Cerebral gliomas; prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002; 44: 656-66.
24. Tedeschi G, Lundbom N, Raman R et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopic imaging study. J Neurosurg 1997; 87: 516-24.
25. Fulham MJ, Bizzi A, Dietz MJ et al. Mapping of brain tumour metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992; 185: 675-86.
26. Shimizu H, Kumabe T, Tominaga T et al. Non-invasive evalaution of malignanacy of brain tumours with proton MR spectroscopy. AJNR 1996; 17: 737-47.
27. Meyerand ME, Pipas M, Mamourian A et al. Classification of biopsy conformed brain tumours using single voxel MR spectroscopy. AJNR 1999; 20: 117-23.
28. Gupta RK, Sinha U, Cloughesy TF, Alger JR. Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med 1999; 41: 2-7.